RE:RE:RE:LABSDefinitely no BIG NEWS coming here. Pfizer is not the partner, DEA probably won't approve as Schedule 3, and FDA has aleady approved LSD as a Breakthrough Therapy Drug for anxiety before cannabis gets approved., if ever. Germany is a bright spot with 220,000 medical cannabis patients but that market will take time. The reality is LABS is where it's at for a reason and it won't vhange until they start making money. Might be a few years. And yes, I meant revenue. $10M would be very disappointing, imo.